COVID-19 and rheumatology: Reflecting on the first wave and preparing for the second wave

Int J Rheum Dis. 2021 Jan;24(1):7-9. doi: 10.1111/1756-185X.14062.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / transmission
  • Clinical Decision-Making
  • Communicable Disease Control / trends*
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Practice Patterns, Physicians' / trends
  • Rheumatic Diseases / drug therapy*
  • Rheumatic Diseases / immunology
  • Rheumatologists / trends
  • Rheumatology / trends*
  • Risk Assessment
  • Risk Factors

Substances

  • Antirheumatic Agents
  • Immunosuppressive Agents